We have over 12,000 students, from over 100 countries, within one of the safest campuses in the UK


93% of Lancaster students go into work or further study within six months of graduating

Home > Research > Researchers > Rachael Rigby
View graph of relations

Current Postgraduate Research Students

Rachael Rigby supervises 6 postgraduate research students. Some of the students have produced research profiles, these are listed below:

« Back

Dr Rachael Rigby


Rachael Rigby

Furness Building

Lancaster University


Lancaster LA1 4YG

United Kingdom

Tel: +44 1524 593420


Research overview

Dr. Rigbys research interests lie in mechanisms of intestinal epithelial cell (IEC) renewal and repair, focusing on the role of Suppressor of Cytokine Signalling 3 in controlling IEC homeostasis.

She is currently investigating how bacterial signals may be linked to the dysregulation of IEC repair seen inflammatory bowel disease and cancer.

Research Interests


Colon cancer is the second leading cause of cancer related death in the UK. Potential reasons why colon cancer is on the increase in the western world include changes in diet and in the types of bacteria residing in our gut. Microbes aid in the digestion and absorption of nutrients and energy from food and guard against harmful bacteria. However, due to our present nutrient and energy rich diets, and clean lifestyles, changes in number or types of bacteria in our gut may be contributing to cancer.

The cells lining our intestine, epithelial cells (IEC) recognise bacteria through a group of transmembrane receptors termed Toll-like receptors (TLR). Engagement of TLR receptors by bacterial products activates signalling pathways within the cell leading to "inflammation" and division of epithelial cells, prerequisites to the development of cancer.


My research interests lie in mechanisms of repair and renewal of the intestinal epithelium. During diseases such as colon cancer and inflammatory bowel disease (IBD), epithelial repair homeostasis is disrupted. My research focuses on the interplay between luminal bacteria and the epithelium through a family of proteins termed suppressors of cytokine signalling (SOCS) which are important mediators of cancer and inflammation.

SOCS3 is silenced in many tumour types and influences growth of IEC. We are currently exploring factors which influence the expression of SOCS3 in IEC, focusing on the effects of bacteria and cytokines.

Current Teaching

BIOL131 Introduction to Biomedical Science: lecturer
BIOL243 Medical Microbiology: module convenor  
BIOL353 Cancer: Lecturer  
BIOL321 Immunology: Lecturer                                                                 
Study Abroad Advisor for Biology
Special Study Module convenor on the Medicine MBChB degree

View all (14) »